Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - September, 2004
45 articles
- E.U. Eyes Six-Month Marketing Exclusivity For Pediatric Testing
- Immunomedics Settles Patent Suit Vs. Cytogen
- Court Denies Preliminary Injunction In Thermage Patent Suit Vs. Syneron
- Impax Gets FDA OK For Generic Oxycontin
- Medtronic Slapped With $110M In Damages In Patent Suit Over Medical Devices
- Court Awards Integra LifeSciences $6.4M In Patent Suit Vs. Merck KGaA
- Trial Date Set In OraSure Patent Suit Vs. Schering-Plough
- Pfizer Appeals China's Decision To Overturn Viagra Patent
- Judge Postpones Hearing On Pfizer Bid To Block Neurontin Generic
- Knobbe Martens Expands Staff
- India Eyes System For Pre-Grant Patent Opposition In New Patent Regime
- Judge Adjourns Injunction Hearing In Neurontin Case
- Gen-Probe To Pay $22.5M To Settle Patent Dispute With Abbott Unit
- Cooley Hires Biotech Patent Attorneys For Reston Office
- European Court Of Justice Could Kill Cross-Border Injunctions In Patent Cases
- Drug Companies Target India For R&D Under New Patent Regime
- Novartis Sues Teva Over ANDA For Generic Lotrel
- Judge Overturns $7.1M Jury Verdict Vs. Umbilical-Cord Blood Banks
- Lee Osman Tapped To Head Dorsey's IP Group
- Pfizer Lobbies China's IP Office To Restore Viagra Patent
- U.S. Mulls Reinstating Israel On IPR Blacklist
- AstraZeneca Sues KV Pharma Over ANDA For Toprol-XL Generic
- American Medical Systems To Pay $2.5M To Settle Patent Dispute With Mentor
- Schwarz To Push For Damages In Univasc Patent Suit Vs. Teva
- U.S. Sends IP Attaché To China Embassy
- Alpharma Asks Appeals Court To Remove Stay On Neurontin Capsule Launch
- Israel Prepares For Clash With U.S., E.U. Over Drug Patent Policy
- Teva Agrees To Suspend Sales Of Moexipril Pending Patent Suit Outcome
- Roche To Pay Chiron $78M To Settle Patent Dispute
- Suit Claims Albertson's, Drug Companies Abused Prescription Records
- India's Generic Industry Sounds Alarm Over Planned Patent Overhaul
- India Stays Exclusive Marketing Rights For Eli Lilly's Cialis
- Israel Mulls IP Bill That Would Defy U.S., European Demands
- Applera Sues Thermo Electron Over Mass Spectrometer Patent
- Novo Nordisk To Appeal Decision On Norditropin
- FDA Holds Off On Biogenerics Decision
- Novartis Faces Uphill Battle For Patent Extensions In Europe
- China Defends Decision To Revoke Viagra Patent
- Otsuka Seeks Re-Examination Of Abilify Patent Due To Error In Original Filing
- Pfizer Sues 18 Online Vendors of "Generic" Lipitor
- Novartis Prevails In Patent Suit Vs. Dr. Reddy's Over Lamisil
- Impax Loses Bid For Generic Version Of Rilutek
- Federal Circuit Sends Guidant's $140M Lawsuit Vs. St. Jude Back To District Court
- Serono Sues Cell Genesys Over TKT Gene Activation Patent
- Mylan Laboratories To Refile Hatch-Waxman Suit Vs. FDA